Clinical Trial

Restricted Eating Time in the Treatment of Type 2 Diabetes

Study acronym: RESET2
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 16, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The overall aim of the present study is to investigate the effectiveness of implementing a 1-year time-restricted eating (TRE)-based intervention on glycaemic control, body weight and composition, cardiometabolic risk factors, and behaviour in individuals with overweight/obesity and type 2 diabetes (T2D).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-11-28; most recent amendment 2025-05-13.
Status change: Not Yet Recruiting → Recruiting 2024-04-10
Trial Details
NCT Number NCT06152588
Lead Sponsor Steno Diabetes Center Copenhagen
Collaborators: University of Leeds, Salk Institute for Biological Studies, University of Copenhagen, Glostrup University Hospital, Copenhagen
Conditions Type 2 Diabetes
Enrollment 160 participants
Start Date 2024-03-21
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-16